Celia Fontanillo
About Celia Fontanillo
Celia Fontanillo is a Principal Scientist in Computational Biology at Bristol Myers Squibb in San Diego, California. She has extensive experience in computational biology and cancer research, having previously worked at Celgene and various research institutions in Spain and the United States.
Current Role at Bristol Myers Squibb
Celia Fontanillo is serving as the Principal Scientist in Computational Biology at Bristol Myers Squibb. She has held this position since June 2020 and is based in San Diego, California. In her role, she applies computational methods and biological insights to support drug discovery and development efforts at the company.
Professional Experience at Celgene
Before joining Bristol Myers Squibb, Celia Fontanillo worked at Celgene in various capacities. She held the title of Senior Scientist for 1 year from 2019 to 2020 in San Diego, California. Prior to that, she was a Senior Scientist for 10 months at the Celgene Institute for Translational Research Europe in Seville, Spain. She initially joined Celgene as a Research Scientist and held that role from 2013 to 2016, followed by a position as Scientist II, Computational Biology from 2016 to 2018. Her tenure at Celgene spanned several key research roles, contributing extensively to the institute's projects focused on translational research.
Educational Background
Celia Fontanillo's educational background is rooted in both biology and computer science. She earned her PhD in Biology and Clinic of Cancer from Universidad de Salamanca, where she studied from 2008 to 2013. She also received a Diploma of Advanced Studies in Biology and Clinic of Cancer between 2007 and 2009. Earlier, she completed a Master's degree in Computer Science from 2004 to 2007, and a Bachelor of Science in Computer Systems Engineering from 2000 to 2004, all at Universidad de Salamanca.
Research and Academic Positions
Celia Fontanillo has held several research and academic positions. She was a Research Associate at the Centro de Investigación del Cáncer (IBMCC-FICUS) in Salamanca, Spain, from 2012 to 2013. She completed her PhD research at the same institution from 2008 to 2012. Additionally, she has experience as a short-term visiting scientist at the Dana-Farber Cancer Institute in 2010 and at the CSIC in 2009. Early in her career, she worked briefly as a Bioinformatician at CIBER BBN in 2007 and held a summer scholarship at Instituto de Astrofísica de Canarias in 2006.